Dr. James Edward Hoffman, MD

Dr. Hoffman practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Hoffman's NPI, 1427214147, was assigned on August 1, 2008. Dr. Hoffman graduated from Albert Einstein College of Medicine in 2002. Dr. Hoffman holds Florida license ME104429.

Dr. Hoffman's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Hoffman's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Hoffman is also affiliated with Cleveland Clinic Weston Hospital. The medical group on file is University of Miami Health System.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hoffman practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Hoffman's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Hoffman is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Hoffman's licenses on file in 2 states: Florida and New York.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, lung cancer, lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Hoffman treats.

CMS data shows 1,296 Medicare services from Dr. Hoffman across 5 procedure codes in 2024, for 404 Medicare patients. Medicare paid $91,591 for them.

CMS counts 404 Medicare patients who saw Dr. Hoffman in 2024. The largest group is 65 to 74, with 170 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hoffman's median patient age at 74, with 47% women.

In 2024, Dr. Hoffman wrote 477 Medicare Part D claims for 127 patients. 82% of them were for generic drugs. CMS names the drug for 321 of them, across 9 drugs with 11 or more claims each, at $17,699 in total drug cost. In 2023, CMS named 284 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Hoffman for performance year 2024, reported as part of a group. Dr. Hoffman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hoffman as offering telehealth.

Dmand AI links 28 papers to Dr. Hoffman, published from 2008 to 2024. 2023 was the busiest year, with 5. The most frequent topics are Multiple Myeloma, Cardiomyopathies and Amyloid Neuropathies, Familial. Dr. Hoffman has published most often in Am J Cardiol. Dr. Hoffman's most frequent co-authors are Dickran Garo Kazandjian, MD, Raymond L. Comenzo, MD and Benjamin Diamond.

Dmand AI links Dr. Hoffman to 4 clinical trials. 1 is still active or recruiting. Conditions studied include Multiple Myeloma, Blood Protein Disorders and Carpal Tunnel Syndrome. University of Miami sponsors the most, 2. Open Payments lists research payments to Dr. Hoffman that name 1 trial.

CMS Open Payments shows 190 general payments to Dr. Hoffman from 18 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 77% of the total. Celgene Corporation paid the most, $91,388. It also lists 78 research payments totaling $30,776 from 2020 to 2025, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Hoffman, most recently CMS Stage 1 EHR in 2012.

Dr. Hoffman graduated from Albert Einstein College of Medicine in 2002.

Dr. Hoffman is in network with 9 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.